CD34 and myelodysplastic syndrome: A study found that when healthy hematopoietic cells are exposed to MDS-associated MSCs, they will have a toxic effect on CD34+ HSPCs, and this effect is persistent, especially in high-risk patients, making this phenomenon is more evident (47).